The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 07, 2020

Filed:

Jan. 13, 2017
Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Leon M. Smith, II, Somerset, NJ (US);

Vladimir Ladziata, Ewing, NJ (US);

Indawati De Lucca, Pennington, NJ (US);

Donald J. P. Pinto, Churchville, PA (US);

Michael J. Orwat, New Hope, PA (US);

Andrew K. Dilger, Ewing, NJ (US);

Kumar Balashanmuga Pabbisetty, Piscataway, NJ (US);

Wu Yang, Princeton Junction, NJ (US);

Scott A. Shaw, Lawrence Township, NJ (US);

Peter W. Glunz, Yardley, PA (US);

Manoranjan Panda, Bangalore, IN;

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 513/04 (2006.01); C07D 213/64 (2006.01); A61P 15/10 (2006.01); A61P 9/10 (2006.01); C07D 239/06 (2006.01);
U.S. Cl.
CPC ...
C07D 513/04 (2013.01); A61P 9/10 (2018.01); A61P 15/10 (2018.01); C07D 213/64 (2013.01); C07D 239/06 (2013.01);
Abstract

The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically-acceptable salts thereof wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.


Find Patent Forward Citations

Loading…